Researchers at Ca’ Foscari University of Venice have transformed ordinary brewer’s yeast into miniature factories for producing and screening therapeutic peptides. Their new method, published in Nature Communications, enables the rapid and environmentally friendly discovery of macrocyclic peptides — highly promising drug candidates for precision medicine.
Read on